Advanced diagnosis and therapy for pulmonary arterial hypertension
J Qi, Y Xing, X Zhao, D Zhu, X Zheng - Nano Life, 2020 - World Scientific
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and progressive disease, which often leads to premature death …
clinical conditions and progressive disease, which often leads to premature death …
[HTML][HTML] Pulmonary arterial hypertension: Emerging principles of precision medicine across basic science to clinical practice
NJ Kelly, SY Chan - Reviews in cardiovascular medicine, 2022 - ncbi.nlm.nih.gov
Pulmonary arterial hypertension (PAH) is an enigmatic and deadly vascular disease with no
known cure. Recent years have seen rapid advances in our understanding of the molecular …
known cure. Recent years have seen rapid advances in our understanding of the molecular …
Future perspectives in pulmonary arterial hypertension
LJ Rubin - Pulmonary Vascular Disorders, 2012 - karger.com
In a remarkably short interval of time, pulmonary artery hypertension (PAH) has evolved from
a disease of unknown pathogenesis devoid of effective therapy to a condition whose cellular …
a disease of unknown pathogenesis devoid of effective therapy to a condition whose cellular …
Pulmonary arterial hypertension: promising advances and remaining challenges
K El-Kersh, JD Dickinson - Journal of Investigative Medicine, 2021 - journals.sagepub.com
Pulmonary arterial hypertension (PAH) diagnosis and management have evolved over the
years. Despite advances in management that resulted in an overall improvement of disease …
years. Despite advances in management that resulted in an overall improvement of disease …
[HTML][HTML] New progress in diagnosis and treatment of pulmonary arterial hypertension
Z Zhang, S Zhu, M Wang, X Wang, X Tong… - Journal of …, 2022 - Springer
Pulmonary arterial hypertension (PAH) is a progressive disease. Although great progress
has been made in its diagnosis and treatment in recent years, its mortality rate is still very …
has been made in its diagnosis and treatment in recent years, its mortality rate is still very …
Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension
M Barrier, J Meloche, MH Jacob, A Courboulin… - Cellular and Molecular …, 2012 - Springer
The pathobiology of pulmonary arterial hypertension (PAH) involves a remodeling process
in distal pulmonary arteries, as well as vasoconstriction and in situ thrombosis, leading to an …
in distal pulmonary arteries, as well as vasoconstriction and in situ thrombosis, leading to an …
[HTML][HTML] Molecular and genetic profiling for precision medicines in pulmonary arterial hypertension
S Fazal, M Bisserier, L Hadri - Cells, 2021 - mdpi.com
Pulmonary arterial hypertension (PAH) is a rare and chronic lung disease characterized by
progressive occlusion of the small pulmonary arteries, which is associated with structural …
progressive occlusion of the small pulmonary arteries, which is associated with structural …
[HTML][HTML] Translational Advances in the Field of Pulmonary Hypertension.Focusing on Developmental Origins and Disease Inception for the Prevention of …
Persistent challenges in managing pulmonary vascular disease progression and poor
outcomes, despite the aggressive use of current drug therapies, highlight the need for …
outcomes, despite the aggressive use of current drug therapies, highlight the need for …
[HTML][HTML] Evaluation and classification of pulmonary arterial hypertension
S Sahay - Journal of thoracic disease, 2019 - ncbi.nlm.nih.gov
In early 2019, the 6th World Symposium on Pulmonary Hypertension (WSPH) released an
updated document highlighting the advances in the last five years. During the quinquennial …
updated document highlighting the advances in the last five years. During the quinquennial …
The evolving management and treatment options for patients with pulmonary hypertension: Current evidence and challenges
JW Swisher, E Weaver - Vascular Health and Risk Management, 2023 - Taylor & Francis
Pulmonary hypertension may develop as a disease process specific to pulmonary arteries
with no identifiable cause or may occur in relation to other cardiopulmonary and systemic …
with no identifiable cause or may occur in relation to other cardiopulmonary and systemic …